Viewing Study NCT04323956


Ignite Creation Date: 2025-12-24 @ 11:21 PM
Ignite Modification Date: 2026-01-04 @ 8:18 AM
Study NCT ID: NCT04323956
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-10
First Post: 2020-03-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma
Sponsor: Mayo Clinic
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module